Skip to main content

Judd Wendell Moul

James H. Semans, M.D. Distinguished Professor of Urologic Surgery, in the School of Medicine
Urology
Box 3707 Med Ctr, Durham, NC 27710
1562 Blue Zone, Duke South, Durham, NC 27710

Scholarly Works - Conferences


Characterizing the activity of inflammasome genes and their association with oncological outcomes in prostate cancer.

Conference Journal of Clinical Oncology · February 10, 2025 410Background: Inflammasomes are multiprotein complexes that regulate inflammation-associated signaling pathways. Although in ... Full text Cite

Cognitive and Cerebrospinal Fluid Alzheimer's Disease-related Biomarker Trajectories in Older Surgical Patients and Matched Nonsurgical Controls.

Conference Anesthesiology · May 1, 2024 BACKGROUND: Anesthesia and/or surgery accelerate Alzheimer's disease pathology and cause memory deficits in animal models, yet there is a lack of prospective data comparing cerebrospinal fluid (CSF) Alzheimer's disease-related biomarker and cognitive traje ... Full text Link to item Cite

Real-world analyses of mortality risk after androgen deprivation therapy initiation in Black vs. White patients with prostate cancer.

Conference Journal of Clinical Oncology · February 1, 2024 84 Background: 2 studies found significantly longer overall survival in Black vs. White patients with metastatic castration-resistant prostate cancer (PCa): a 2019 meta-analysis of 9 phase III trials and a 2020 registry study. Ou ... Full text Cite

Re-thinking How We Use Prostate Health Index for African American Men.

Conference Urology · May 2023 OBJECTIVE: To assess how the validated Prostate Health Index (PHI) risk stratifications perform with African American (AA) men and establish a threshold PHI value to potentially rule out the need for prostate biopsy. MATERIALS AND METHODS: AA men meeting F ... Full text Link to item Cite

Interim analysis of a prospective randomized trial of dietary carbohydrate restriction for men with a rising PSA after failed primary treatment: Carbohydrate and Prostate Study 2 (CAPS2).

Conference Journal of Clinical Oncology · February 20, 2018 382 Background: Nearly one third of men treated with curative intent for localized prostate cancer (PC) will develop a rising PSA. The rate of PSA rise (PSA doubling time aka PSASDT) is a predictor metastases and PC death. In lab ... Full text Cite

Evaluation of microarrays for measuring cell cycle progression (CCP) gene expression.

Conference Journal of Clinical Oncology · May 20, 2017 e16566 Background: A CCP score has been developed and validated to provide prognostic information in prostate cancer. To date, our studies have exclusively used qRT-PCR to measure CCP gene expression, which is generally considere ... Full text Cite

Head-to-head pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprorelin acetate formulations in male patients.

Conference Journal of Clinical Oncology · February 20, 2017 e589 Background: Leuprolide acetate (LA) is the standard-of-care luteinizing hormone-releasing hormone (LHRH) agonist used to suppress serum testosterone (T) in the treatment of advanced prostate cancer. There are currently two L ... Full text Cite

A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.

Conference Prostate Cancer Prostatic Dis · March 2016 BACKGROUND: In men with high Gleason PC and rapid PSA progression after surgery, failure rates remain unacceptably high despite salvage radiation. We explored a novel multimodality approach of docetaxel with anti-angiogenic therapy before salvage radiother ... Full text Link to item Cite

Application of active surveillance threshold to series of samples submitted for commercial testing.

Conference Journal of Clinical Oncology · January 10, 2016 84 Background: Active surveillance (AS) is an increasingly popular treatment modality for men with localized prostate cancer. Recently, we developed a method to select men for AS based on a score that combines cell cycle progress ... Full text Cite

Image Guidance Affects Biochemical Outcome for Postprostatectomy Radiation Therapy

Conference International Journal of Radiation Oncology*Biology*Physics · October 2013 Full text Cite

Value of NADiA ProsVue on the CAPRA-S nomogram for predicting postprostatectomy clinical recurrence.

Conference Journal of Clinical Oncology · February 20, 2013 139 Background: The post-radical prostatectomy (RP) CAPRA-S nomogram stratifies men into low, intermediate and high risk groups for biochemical recurrence (BCR) and proved accurate for predicting 3 and 5 year BCR rates in a large ... Full text Cite

Post-prostatectomy PSA slope (ProsVue) in Gleason score >= 7 disease

Conference JOURNAL OF CLINICAL ONCOLOGY · May 20, 2012 Link to item Cite

3D Conformal and Intensity Modulated Radiotherapy to the Prostate Bed have Similar Biochemical Outcomes

Conference International Journal of Radiation Oncology*Biology*Physics · October 2011 Full text Cite

Neoadjuvant Radiotherapy plus Prostatectomy for High Risk Prostate Cancer

Conference International Journal of Radiation Oncology*Biology*Physics · October 2011 Full text Cite

Prognostic impact of post-prostatectomy PSA slope determined with a novel, nucleic acid detection immunoassay (NADiA ProsVue) for total PSA.

Conference Journal of Clinical Oncology · March 1, 2011 47 Background: ProsVue is an investigational PSA immunoassay whose reporter antibody is labeled with a synthetic DNA sequence. RT-PCR detects the DNA signal indicating the PSA concentration. Pilot studies showed ProsVue slope (le ... Full text Cite

Prostate-specific antigen (PSA) progression-free survival (PFS): A comparison of degarelix versus leuprolide in patients with prostate cancer.

Conference Journal of Clinical Oncology · March 1, 2011 12 Background: Comparative effectiveness of the gonadotropin-releasing hormone (GnRH) blocker, degarelix, vs the GnRH agonist, leuprolide, was evaluated during a 1-year phase III trial (CS21); data have been presented. We now rep ... Full text Cite

Salvage Radiation in Men with PSA Failure following Radical Prostatectomy and the Risk of Death

Conference International Journal of Radiation Oncology*Biology*Physics · November 2010 Full text Cite

What Factors Influence Referral for Postoperative Radiation Therapy for Prostate Cancer?

Conference International Journal of Radiation Oncology*Biology*Physics · September 2008 Full text Cite

Distribution of prostate cancer for optimized biopsy protocols

Conference Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics · January 1, 2000 Prostate cancer is the leading cause of death for American men. The gold standard for diagnosis of prostate cancer is transrectal ultrasound-guided needle core biopsy. Unfortunately, no imaging modality, including ultrasound, can effectively differentiate ... Full text Cite

3-D model supported prostate biopsy simulation and evaluation

Conference Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics · January 1, 1998 The diagnosis of localized prostate cancer is carried out by standard core needle biopsies under guidance of transrectal ultrasound imaging of the prostate gland. This paper describes a 3-D model supported virtual environment for prostate cancer diagnosis ... Full text Cite

3D model supported virtual environment for prostate disease interpretation and biopsy design

Conference Proceedings Pacific Medical Technology Symposium Transcending Time Distance and Structural Barriers Pacmedtek 1998 · January 1, 1998 The diagnosis of localized prostate cancer is carried out by standard core needle biopsies under guidance of transrectal ultrasound imaging of the prostate gland. This paper describes a 3D model supported virtual environment for prostate cancer diagnosis a ... Full text Cite

Comparison of prostate biopsy protocols using 3D computer simulation

Conference Proceedings Pacific Medical Technology Symposium Transcending Time Distance and Structural Barriers Pacmedtek 1998 · January 1, 1998 To detect prostate cancer urologists routinely use the systematic sextant needle biopsy technique. This patterned biopsy technique has been adopted with little quantitative or scientific evidence to support its use. Using 136 digitized radical prostatectom ... Full text Cite